9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Clinical and Histopathologic Characteristics of BAP1 Mutations

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Clinical and Histopathologic Characteristics of BAP1 Mutations

Clinical and Histopathologic Characteristics of BAP1 Mutations

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma (MPM)

Estimated Enrollment: 196

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: determine the prevalence of germline BAP1 mutations,  prevalence of somatic BAP1 mutations in disease mesothelioma and metastatic uveal melanoma.,  ,

Interventions: tumor specimens,

Phase:

Study Type: Observational

Study Design: Observational Model: Cohort, Time Perspective: Prospective, ,

Primary Completion Date: January 2020

Completion Date: January 2020

Last  Posted Date: March 1, 2019

Location: Memorial Sloan Kettering Westchester, Harrison, New York, United States

Website Link: https://ClinicalTrials.gov/show/NCT01773655

Was this article helpful?
Dislike 0